ArticleFrontiers in pharmacology2017

Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice.

Yongchuan Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.